Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.
Frequently asked questions
What sector does Integral Diagnostics Limited (ITGDF) operate in?
Integral Diagnostics Limited belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Integral Diagnostics Limited (ITGDF) current stock price?
As of the latest data, Integral Diagnostics Limited stock price is $2.61, with a previous close of $2.61.
What is Integral Diagnostics Limited (ITGDF) current market capitalization?
Integral Diagnostics Limited market cap is approximately 974.64 million.
What is Integral Diagnostics Limited (ITGDF) Earnings Per Share (EPS)?
The trailing EPS is $0.04.
What is Integral Diagnostics Limited (ITGDF) Price-to-Earnings (P/E) ratio?
Integral Diagnostics Limited current P/E ratio is 65.31.
Does Integral Diagnostics Limited (ITGDF) pay dividends?
Yes. Integral Diagnostics Limited pays semiannual dividends with an annualized yield of 2.53% and an estimated annual payout of $0.07 per share.
When is the next ex-dividend date for Integral Diagnostics Limited (ITGDF)?
The next ex-dividend date is scheduled for March 01, 2027.
What is Integral Diagnostics Limited (ITGDF) beta (volatility) score?
Integral Diagnostics Limited has a beta of 0.145, indicating lower volatility than the overall market.
